Journal
JOURNAL OF CLINICAL NEUROPHYSIOLOGY
Volume 38, Issue 6, Pages 485-493Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WNP.0000000000000735
Keywords
Centromedian nucleus; Neuromodulation; Epilepsy surgery; Bilateral deep brain stimulation; Refractory epilepsy; Generalized seizures
Categories
Ask authors/readers for more resources
The Centromedian thalamic nucleus is a large nucleus with extensive connectivity to the cerebral cortex and basal ganglia. Deep brain stimulation has been proposed as a method to interfere with seizure genesis or propagation, with seizure control ranging between 69% and 83% in different reports.
Centromedian thalamic nucleus is an intralaminar nucleus with vast connectivity to cerebral cortex and basal ganglia. It receives afferents from the brain stem through the central tegmental tract and is part of the diffuse thalamic projection system. Because the reticulothalamic system has been related to initiation and propagation of epileptic activity (centroencephalic theory of epilepsy), deep brain stimulation has been proposed to interfere with seizure genesis or propagation. Centromedian thalamic nucleus is a large nucleus laying nearby the anatomical references for stereotaxis and therefore a convenient surgical target to approach. Electrodes are implanted in the anterior ventral lateral part of the nucleus (parvocellular area), guided by intraoperative recruiting responses elicited by unilateral 6 to 8 Hz electrical stimulation delivered through the deep brain stimulation electrode. Therapeutic stimulation is delivered with the following parameters: 60 Hz, 450 mu s, 3.0 V. Seizure control runs between 69% and 83% in different reports, decreasing mainly generalized seizures from the start, with significant improvement in neuropsychological performance. Significant decrease in seizure occurs from hours to days after the onset of deep brain stimulation. Some reports refer that seizure improvement may occur by the simple insertion of the deep brain stimulation electrodes, and therefore, it was used to treat refractory epileptic status.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available